Pre-operative Redox State Affects 1-Month Survival in Patients With Advanced Heart Failure Undergoing Left Ventricular Assist Device Implantation

Preliminary findings suggest that adequate activity of the GPx-1-based anti-oxidant system before device placement is associated with patient survival up to 1 month, despite comparable baseline oxidative stress in patients who both survived and died (within 2 weeks post-LVAD).